173 related articles for article (PubMed ID: 32086055)
1. Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT
Wróbel MZ; Chodkowski A; Marciniak M; Dawidowski M; Maksymiuk A; Siwek A; Nowak G; Turło J
Bioorg Chem; 2020 Apr; 97():103662. PubMed ID: 32086055
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT
Wróbel MZ; Chodkowski A; Dawidowski M; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Satała G; Bojarski AJ; Turło J
Bioorg Chem; 2023 Dec; 141():106903. PubMed ID: 37827015
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect.
Wróbel MZ; Chodkowski A; Herold F; Marciniak M; Dawidowski M; Siwek A; Starowicz G; Stachowicz K; Szewczyk B; Nowak G; Belka M; Bączek T; Satała G; Bojarski AJ; Turło J
Eur J Med Chem; 2019 Dec; 183():111736. PubMed ID: 31586817
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT(1A) receptor and the serotonin transporter.
Shen Z; Siva Ramamoorthy P; Hatzenbuhler NT; Evrard DA; Childers W; Harrison BL; Chlenov M; Hornby G; Smith DL; Sullivan KM; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2010 Jan; 20(1):222-7. PubMed ID: 19932965
[TBL] [Abstract][Full Text] [Related]
6. Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor.
Zhou D; Hatzenbuhler NT; Gross JL; Harrison BL; Evrard DA; Chlenov M; Golembieski J; Hornby G; Schechter LE; Smith DL; Andree TH; Stack GP
Bioorg Med Chem Lett; 2007 Jun; 17(11):3117-21. PubMed ID: 17407811
[TBL] [Abstract][Full Text] [Related]
7. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
[TBL] [Abstract][Full Text] [Related]
8. Studies towards the next generation of antidepressants. Part 4: derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor.
Evrard DA; Zhou P; Yi SY; Zhou D; Smith DL; Sullivan KM; Hornby GA; Schechter LE; Andree TH; Mewshaw RE
Bioorg Med Chem Lett; 2005 Feb; 15(4):911-4. PubMed ID: 15686885
[TBL] [Abstract][Full Text] [Related]
9. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia.
Rotella DP; McFarlane GR; Greenfield A; Grosanu C; Robichaud AJ; Denny RA; Feenstra RW; Núñez-García S; Reinders JH; Neut Mv; McCreary A; Kruse CG; Sullivan K; Pruthi F; Lai M; Zhang J; Kowal DM; Carrick T; Grauer SM; Navarra RL; Graf R; Brennan J; Marquis KL; Pausch MH
Bioorg Med Chem Lett; 2009 Oct; 19(19):5552-5. PubMed ID: 19720528
[TBL] [Abstract][Full Text] [Related]
11. 6-Acetyl-5-hydroxy-4,7-dimethylcoumarin derivatives: Design, synthesis, modeling studies, 5-HT
Ostrowska K; Leśniak A; Karczyńska U; Jeleniewicz P; Głuch-Lutwin M; Mordyl B; Siwek A; Trzaskowski B; Sacharczuk M; Bujalska-Zadrożny M
Bioorg Chem; 2020 Jul; 100():103912. PubMed ID: 32388437
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
[TBL] [Abstract][Full Text] [Related]
13. Introduction of a new complex imide system into the structure of LCAPs. The synthesis and a 5-HT1A, 5-HT2A and D2 receptor binding study.
Kossakowski J; Raszkiewicz A; Bugno R; Bojarski AJ
Pol J Pharmacol; 2004; 56(6):843-8. PubMed ID: 15662099
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
[TBL] [Abstract][Full Text] [Related]
15. Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity.
Heinrich T; Böttcher H; Schiemann K; Hölzemann G; Schwarz M; Bartoszyk GD; van Amsterdam C; Greiner HE; Seyfried CA
Bioorg Med Chem; 2004 Sep; 12(18):4843-52. PubMed ID: 15336263
[TBL] [Abstract][Full Text] [Related]
16. Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.
Hatzenbuhler NT; Baudy R; Evrard DA; Failli A; Harrison BL; Lenicek S; Mewshaw RE; Saab A; Shah U; Sze J; Zhang M; Zhou D; Chlenov M; Kagan M; Golembieski J; Hornby G; Lai M; Smith DL; Sullivan KM; Schechter LE; Andree TH
J Med Chem; 2008 Nov; 51(21):6980-7004. PubMed ID: 18834188
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.
Perrone R; Berardi F; Colabufo NA; Lacivita E; Larizza C; Leopoldo M; Tortorella V
J Pharm Pharmacol; 2005 Oct; 57(10):1319-27. PubMed ID: 16259761
[TBL] [Abstract][Full Text] [Related]
18. Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia.
Yan Y; Zhou P; Rotella DP; Feenstra R; Kruse CG; Reinders JH; van der Neut M; Lai M; Zhang J; Kowal DM; Carrick T; Marquis KL; Pausch MH; Robichaud AJ
Bioorg Med Chem Lett; 2010 May; 20(9):2983-6. PubMed ID: 20347298
[TBL] [Abstract][Full Text] [Related]
19. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
[TBL] [Abstract][Full Text] [Related]
20. Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT
Yoshinaga H; Nishida T; Sasaki I; Kato T; Oki H; Yabuuchi K; Toyoda T
Bioorg Med Chem; 2018 May; 26(8):1614-1627. PubMed ID: 29456112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
